BNTX BioNTech Inc.: Accounting Value per Share
Stable cash flow from core drugs supports the financial stability of BioNTech SE (BNTX). The estimated book value per share reflects asset accumulation, where the value of 81.06 serves as the baseline indicator. BioNTech SE (BNTX) is implementing sustainable production standards and bioethics, yet faces risks of declining vaccine demand and single-product dependency, which could negatively impact its capitalization.
biontech.de - analytical breakdowns and key metrics (BNTX)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:BioNTech Group - BNTX
BioNTech SE (BNTX) requires colossal initial R&D investments to enable subsequent low-cost scaling of profits. Book value per share is calculated as the ratio of equity to the number of issued shares, determining the asset's intrinsic value. Analyzing this book value per share allows investors to filter out market noise from real assets. Growth in this metric confirms the capitalization of intellectual property, while a stable trend guarantees fundamental capital protection for the investor.
Competitors of BioNTech SE (BNTX)
Accounting Value per Share Argenx ARGX|Abivax Pharma (ABVX) - Book Price of a Share|Accounting Value per Share ADMA Biologics|PTGX (protagonist-inc.com) - Equity per Share|Net Assets per Single Share Immunovant IMVT|Share Book Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Book Value per Share|Accounting Value of a Share Adaptive Biotechnologies Inc. (ADPT)|Book Value per Share CLDX (Celldex Therapeutics)|auriniapharma.com - Book Value per Share|Net Assets per Single Share BioCryst Pharmaceuticals (BCRX)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|ENGN - Book Value per Share|RAPT - Net Assets per Single Share|aerovatetx.com - Book Value per Share|ACRS (aclaristx.com) - Net Assets per Share|Net Assets per Single Share KYTX (Kyverna Therapeutics, Inc.)|Net Asset Value per Share TLSA|Net Assets per Single Share Cabaletta Bio, Inc CABA|Equity per Share Ventyx Biosciences, Inc VTYX|Accounting Value per Share Theratechnologies Inc. (THTX)|Book Price of a Share avalotx.com AVTX|ELDN (Eledon Pharmaceuticals, Inc.) - Book Value per Share|AGEN - Net Asset Value per Share|CLYM (Climb Bio, Inc.) - Book Value per Share|Zura Bio Ltd (ZURA) - Accounting Value per Share|ATYR - Book Value per Share|Accounting Value of a Share Adagene Corp (ADAG)|ImageneBio Inc (IMA) - Accounting Value per Share|Accounting Value of a Share STTK (shattucklabs.com)|Net Assets per Single Share EQ|Net Assets per Share Connect Biopharma Holdings CNTB|IMUX (Immunic Inc) - Book Value per Share|ATRA - Net Asset Value per Share|inflarx.de (IFRX) - Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Net Assets per Single Share|Net Assets per Single Share Adicet Bio Inc. (ACET)|Equity per Share Celularity Corp (CELU)|Accounting Value per Share INmune Bio, Inc.|Book Price of a Share barinthusbio.com BRNS|KZR - Accounting Value per Share|SAB Biotherapeutics Inc. - Equity per Share|Net Assets per Single Share Akari Therapeutics plc|ENLV - Share Book Value|Book Value per Share q32bio.com QTTB|geovax.com (GOVX) - Accounting Value of a Share|EDSA (Edesa Biotech) - Book Value per Share|Book Value per Share IBIO|Carisma Therapeutics (CARM) - Net Assets per Single Share|Accounting Value of a Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. - Net Assets per Single Share|Accounting Value per Share HCW Biologics, Inc. HCWB|Aptevo - Book Value per Share|AIM ImmunoTech, Inc. (AIM) - Book Value per Share|Accounting Value per Share aditxt.com ADTX|GRI Bio Corporation (GRI) - Accounting Value of a Share|XRTX: Book Value per Share|Net Assets per Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share INDP (Indaptus Therapeutics Inc)|Scinai - Net Assets per Single Share|CALI - Accounting Value per Share|Affimed Therapeutics - Accounting Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com|IGM Biosciences (IGMS) - Equity per Share|Book Value per Share ITOS (iTeos)|Net Asset Value per Share Ocean Biomedical Corp|Book Value per Share TC Biopharm (TCBP)|Net Assets per Single Share thirdharmonicbio.com (THRD)